SK
Publications
104
Views
35,904
Downloads
13,019
Supervised works
6
Items per page
1 - 104 of 104
Title Published in Access level OA Policy Year Views Downloads
Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studiesMolecular psychiatry
accessLevelPublic
2025 81 23
Effect of seclusion on mental health status in hospitalized psychiatric populations : a trial emulation using observational dataEvaluation & the health professions
accessLevelPublic
2024 71 37
Striatal response to reward anticipation as a biomarker for schizophrenia and negative symptoms : effects, test-retest reliability, and stability across sitesSchizophrenia bulletin
accessLevelPublic
2024 86 35
Experience of violence and attitudes of staff members towards coercion in psychiatric settings : observational studyBJPsych open
accessLevelPublic
2024 90 40
The Cerebellum and Cognitive Function: Anatomical Evidence from a Transdiagnostic SampleCerebellum
accessLevelPublic
2023 59 40
Admissions to psychiatric inpatient services and use of coercive measures in 2020 in a Swiss psychiatric department : An interrupted time-series analysisPloS one
accessLevelPublic
2023 36 58
Neural bases of reward anticipation in healthy individuals with low, mid, and high levels of schizotypyScientific reports
accessLevelPublic
2023 67 27
Cerebellar and cortico-striatal-midbrain contributions to reward-cognition processes and apathy within the psychosis continuumSchizophrenia research
accessLevelPublic
2022 199 83
Increased ventral striatal functional connectivity in patients with schizophrenia during reward anticipationNeuroImage. Clinical.
accessLevelPublic
2022 247 92
Cortical and subcortical neuroanatomical signatures of schizotypy in 3004 individuals assessed in a worldwide ENIGMA studyMolecular psychiatry
accessLevelPublic
2022 243 58
Differential expression of serum extracellular vesicle microRNAs and analysis of target-gene pathways in major depressive disorderBiomarkers in neuropsychiatry
accessLevelPublic
2022 177 174
European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter StudyFrontiers in psychiatry
accessLevelPublic
2022 197 91
The impact of implementing a psychiatric emergency hotline on the reduction of acute hospitalizations in a Swiss tertiary hospitalBMC psychiatry
accessLevelPublic
2021 212 105
EPA guidance on assessment of negative symptoms in schizophreniaEuropean Psychiatry
accessLevelPublic
2021 256 282
How far to go in deconstructing negative symptoms? Behavioural and neural level evidence for the amotivation domainSchizophrenia Research
accessLevelPublic
2021 218 107
Increased random exploration in schizophrenia is associated with inflammationNPJ Schizophrenia
accessLevelPublic
2021 203 104
EPA guidance on treatment of negative symptoms in schizophreniaEuropean Psychiatry
accessLevelPublic
2021 219 118
Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trialsNPJ schizophrenia
accessLevelPublic
2021 232 134
Hepatitis C prevalence in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapyJHEP Reports : Innovation in Hepatology
accessLevelPublic
2021 253 110
Neural mapping of anhedonia across psychiatric diagnoses: A transdiagnostic neuroimaging analysisNeuroImage. Clinical.
accessLevelPublic
2021 176 102
Suicide in psychiatry and medical liability: A case seriesInternational Journal of Law and Psychiatry
accessLevelRestricted
2021 208 0
Prevalence and risk factors for seclusion and restraint in old-age psychiatry inpatient unitsBMC Psychiatry
accessLevelPublic
2021 285 136
Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serumJournal of Psychiatric Research
accessLevelPublic
2021 218 117
Orbitofrontal-Striatal Structural Alterations Linked to Negative Symptoms at Different Stages of the Schizophrenia SpectrumSchizophrenia Bulletin
accessLevelRestricted
2021 201 3
Impact of the COVID-19 Pandemic on Psychiatric Admissions to a Large Swiss Emergency Department: An Observational StudyInternational Journal of Environmental Research and Public Health
accessLevelPublic
2021 290 170
Psychiatric emergency admissions during and after COVID-19 lockdown: short-term impact and long-term implications on mental healthBMC psychiatry
accessLevelPublic
2021 367 173
Associations Between Negative Symptoms and Effort Discounting in Patients With Schizophrenia and Major Depressive DisorderSchizophrenia bulletin open
accessLevelPublic
2021 179 79
Dopamine and Neuroinflammation in Schizophrenia – Interpreting the Findings from Translocator Protein (18kDa) PET ImagingNeuropsychiatric disease and treatment
accessLevelPublic
2021 236 68
Toxicity of psychotropic drugs in patients with COVID-19: A systematic reviewGeneral Hospital Psychiatry
accessLevelPublic
2021 277 175
Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorderScientific Reports
accessLevelPublic
2021 183 75
Peripheral biopterin and neopterin in schizophrenia and depressionPsychiatry Research
accessLevelPublic
2021 197 170
Common and disorder-specific upregulation of the inflammatory markers TRAIL and CCL20 in depression and schizophreniaScientific reports
accessLevelPublic
2021 207 117
Coercive Measures in Psychiatry: A Review of Ethical ArgumentsFrontiers in psychiatry
accessLevelPublic
2021 248 197
A systematic review and meta-analysis of the prevalence of cocaine-induced psychosis in cocaine usersProgress in Neuro-psychopharmacology & Biological Psychiatry
accessLevelPublic
2021 270 742
Intranasal oxytocin for negative symptoms of schizophrenia: systematic review, meta-analysis and dose-response meta-analysis of randomized controlled trialsInternational Journal of Neuropsychopharmacology
accessLevelPublic
2021 225 146
Shared and dissociable features of apathy and reward system dysfunction in bipolar I disorder and schizophreniaPsychological Medicine
accessLevelRestricted
2020 406 7
Cannabis, nicotine and the negative symptoms of schizophrenia: Systematic review and meta-analysis of observational studiesNeuroscience and Biobehavioral Reviews
accessLevelPublic
2020 322 179
Pathophysiology of negative symptom dimensions of schizophrenia - Current developments and implications for treatmentNeuroscience and Biobehavioral Reviews
accessLevelRestricted
2020 390 6
Aberrant striatal coupling with default mode and central executive network relates to self-reported avolition and anhedonia in schizophreniaJournal of Psychiatric Research
accessLevelPublic
2020 225 374
Loss Aversion and Risk Aversion in Non-Clinical Negative Symptoms and HypomaniaFrontiers in Psychiatry
accessLevelPublic
2020 237 98
Clinical, behavioural and neural validation of the PANSS amotivation factorSchizophrenia Research
accessLevelRestricted
2020 273 0
Apathy is not associated with reduced ventral striatal volume in patients with schizophreniaSchizophrenia Research
accessLevelRestricted
2020 235 0
Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMANeuroImage
accessLevelPublic
2020 291 123
Covid-19 et psychiatrie : ouverture en urgence d'une unité de cohortage à la Clinique psychiatrique de GenèveRevue médicale suisse
accessLevelPublic
2020 235 109
Cerebral blood flow in striatal regions is associated with apathy in patients with schizophreniaJournal of Psychiatry and Neuroscience
accessLevelRestricted
2019 285 0
Meditation-based mind-body therapies for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysisSchizophrenia Research
accessLevelRestricted
2019 278 0
Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled TrialsJournal of Clinical Psychopharmacology
accessLevelRestricted
2019 304 1
Physical exercise for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysisGeneral Hospital Psychiatry
accessLevelRestricted
2019 403 0
Psychiatrie : recommandations thérapeutiques suissesRevue médicale suisse
accessLevelPublic
2019 550 414
Effects of Seclusion and Restraint in Adult Psychiatry: A Systematic ReviewFrontiers in Psychiatry
accessLevelPublic
2019 492 224
A large European, multicenter, multinational validation study of the Brief Negative Symptom ScaleEuropean Neuropsychopharmacology
accessLevelPublic
2019 309 294
Subtle white matter alterations in schizophrenia identified with a new measure of fiber densityScientific Reports
accessLevelPublic
2019 339 131
‘Early Stage' instrumental irrationality: lessons from apathyPhilosophy, Psychiatry, & Psychology
accessLevelRestricted
2018 298 0
Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in SchizophreniaSchizophrenia Bulletin
accessLevelPublic
2018 530 329
Psychometric evaluation of the Temporal Experience of Pleasure Scale (TEPS) in a German samplePsychiatry Research
accessLevelPublic
2018 443 940
Combining actigraphy, ecological momentary assessment and neuroimaging to study apathy in patients with schizophreniaSchizophrenia Research
accessLevelRestricted
2018 563 3
The Cognitive Underpinnings of Option Generation in Everyday Life Decision-Making: A Latent Variable AnalysisCognitive science
accessLevelPublic
2018 307 160
Investigating the association of ventral and dorsal striatal dysfunction during reward anticipation with negative symptoms in patients with schizophrenia and healthy individualsPLOS ONE
accessLevelPublic
2018 418 190
Effort-based decision-making paradigms as objective measures of apathy in schizophrenia?Current Opinion in Behavioral Sciences
accessLevelRestricted
2018 311 1
Deficits in context-dependent adaptive coding in early psychosis and healthy individuals with schizotypal personality traitsBrain
accessLevelPublic
2018 422 163
Ventral Striatal Dysfunction and Symptom Expression in Individuals With Schizotypal Personality Traits and Early PsychosisSchizophrenia Bulletin
accessLevelPublic
2018 481 240
Using Functional Analysis as a Framework to Guide Individualized Treatment for Negative SymptomsFrontiers in Psychology
accessLevelPublic
2017 344 195
Secondary negative symptoms - A review of mechanisms, assessment and treatmentSchizophrenia Research
accessLevelRestricted
2017 477 4
Rentenrelevante Arbeitsunfähigkeit und Mini-ICF-APPNeuropsychiatrie
accessLevelRestricted
2017 568 0
Dissecting negative symptoms of schizophrenia: History, assessment, pathophysiological mechanisms and treatmentSchizophrenia Research
accessLevelRestricted
2017 301 0
Deficits in reinforcement learning but no link to apathy in patients with schizophreniaScientific Reports
accessLevelPublic
2017 495 189
Altered reward anticipation: Potential explanation for weight gain in schizophrenia?Neuroscience and Biobehavioral Reviews
accessLevelPublic
2017 514 575
Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatmentSchizophrenia Research
accessLevelRestricted
2017 509 7
Deficits in context-dependent adaptive coding of reward in schizophreniaNPJ Schizophrenia
accessLevelPublic
2016 444 169
The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathyBMC Psychiatry
accessLevelPublic
2016 542 267
Cognitive and Affective Aspects of Creative Option Generation in Everyday Life SituationsFrontiers in Psychology
accessLevelPublic
2016 397 268
Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophreniaJournal of Psychiatry and Neuroscience
accessLevelRestricted
2016 456 4
The translational study of apathy-an ecological approachFrontiers in Behavioral Neuroscience
accessLevelPublic
2015 502 184
Reward System Dysfunction as a Neural Substrate of Symptom Expression Across the General Population and Patients With SchizophreniaSchizophrenia Bulletin
accessLevelPublic
2015 512 195
Reward-dependent modulation of working memory is associated with negative symptoms in schizophreniaSchizophrenia Research
accessLevelPublic
2015 505 443
Apathy in schizophrenia as a deficit in the generation of options for actionJournal of Abnormal Psychology
accessLevelPublic
2015 480 307
Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effortSchizophrenia Bulletin
accessLevelPublic
2015 477 233
The association of neurocognitive impairment with diminished expression and apathy in schizophreniaSchizophrenia Research
accessLevelPublic
2015 495 538
The effects of caffeine on option generation and subsequent choicePsychopharmacology
accessLevelRestricted
2014 433 0
Symptom dimensions are associated with reward processing in unmedicated persons at risk for psychosisFrontiers in Behavioral Neuroscience
accessLevelPublic
2014 424 248
Predictors for improvement of problem-solving during cognitive remediation for patients with SchizophreniaJournal of the International Neuropsychological Society
accessLevelPublic
2014 453 257
Psychiatrischer Versorgungsbedarf in betreuten WohneinrichtungenNeuropsychiatrie
accessLevelRestricted
2014 427 0
Planning impairments in schizophrenia: specificity, task independence and functional relevanceSchizophrenia Research
accessLevelRestricted
2013 474 0
Why we should talk about option generation in decision-making researchFrontiers in Psychology
accessLevelPublic
2013 382 170
The cognitive and neural basis of option generation and subsequent choiceCognitive Affective and Behavioral Neuroscience
accessLevelRestricted
2013 468 1
Parabolic discounting of monetary rewards by physical effortBehavioural Processes
accessLevelRestricted
2013 414 0
Patients' and clinicians' attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosisTherapeutic Advances in Psychopharmacology
accessLevelRestricted
2013 402 0
Temporal variability and spatial diffusion of the N2 event-related potential in high-functioning patients with schizophreniaSchizophrenia Research
accessLevelRestricted
2011 478 1
Psychometric evaluation of the Psychotic Symptom Rating ScalesComprehensive Psychiatry
accessLevelRestricted
2011 440 0
Deficits in fronto-posterior interactions point to inefficient resource allocation in schizophreniaActa Psychiatrica Scandinavica
accessLevelRestricted
2011 479 1
Response inhibition or salience detection in the right ventrolateral prefrontal cortex?Neuroreport
accessLevelRestricted
2011 423 0
The Plan-a-Day approach to measuring planning ability in patients with schizophreniaJournal of the International Neuropsychological Society
accessLevelRestricted
2011 459 0
Planning and problem-solving training for patients with schizophrenia: a randomized controlled trialBMC Psychiatry
accessLevelPublic
2011 491 175
The negative symptoms of schizophrenia: category or continuum?Psychopathology
accessLevelRestricted
2011 435 0
A supramodal network for response inhibitionNeuroreport
accessLevelRestricted
2010 464 0
Neural reward processing is modulated by approach- and avoidance-related personality traitsNeuroImage
accessLevelRestricted
2010 447 0
Motor impulsivity and the ventrolateral prefrontal cortexPsychiatry Research
accessLevelRestricted
2010 474 1
Psychometric evaluation of the characteristics of delusions rating scale as an expert rating scalePsychopathology
accessLevelRestricted
2010 429 0
Neural correlates of reward processing in schizophrenia--relationship to apathy and depressionSchizophrenia Research
accessLevelRestricted
2010 437 0
Dimensions of delusional experience scale: a psychometric evaluation of a german versionPsychopathology
accessLevelRestricted
2010 513 0
Intra-individual variability in high-functioning patients with schizophreniaPsychiatry Research
accessLevelRestricted
2010 485 0
Context representation and thought disorder in schizophreniaPsychopathology
accessLevelRestricted
2010 443 0
Maintenance of real objects and their verbal designations in working memoryNeuroscience Letters
accessLevelPublic
2010 454 413
Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophreniaPharmacopsychiatry
accessLevelRestricted
2006 398 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack